Diaceutics Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	7.34	12.74	16.67	19.84	19.68
Cash & Short-Term Investments	7.34	12.74	16.67	19.84	19.68
Cash Growth	-42.37%	-23.54%	-16.00%	0.84%	-22.10%
Accounts Receivable	21.26	16.04	11.37	9.21	7.62
Other Receivables	0.76	0.74	0.01	1.85	2.77
Total Trade Receivables	22.02	16.79	11.37	11.06	10.39
Total Current Assets	29.36	29.53	28.04	30.9	30.06
Net Property, Plant & Equipment	1.66	1.68	1.9	2.09	2.13
Other Intangible Assets	16.08	15.41	15.26	15.22	12.82
Other Long-Term Assets	2.9	2	1.14	0.05	0
Total Assets	50.01	48.62	46.34	48.26	45.01
Accounts Payable	8.25	7.61	4.24	3.63	2.36
Current Portion of Long-Term Debt	-	-	-	-	0.13
Current Portion of Leases	0.27	0.15	0.15	0.12	0.15
Other Current Liabilities	0.03	0	-	-	-
Total Current Liabilities	8.55	7.77	4.38	3.75	2.63
Long-Term Leases	0.88	0.91	1.06	1.21	1.29
Other Long-Term Liabilities	0.1	0.09	0.12	0.79	0.45
Total Long-Term Liabilities	0.98	1	1.18	1.99	1.73
Total Liabilities	9.53	8.76	5.56	5.74	4.36
Common Stock	0.17	0.17	0.17	0.17	0.17
Treasury Stock	-0.31	-0.31	-0.31	-0.26	-0.17
Additional Paid-in Capital	-	-	37.13	37.13	36.86
Accumulated Other Comprehensive Income	-0.98	-0.63	-0.24	0.14	-0.3
Retained Earnings	41.6	40.63	4.04	5.34	4.08
Shareholders' Equity	40.48	39.86	40.79	42.51	40.65
Total Liabilities & Equity	50.01	48.62	46.34	48.26	45.01
Total Debt	1.15	1.06	1.21	1.33	1.56
Net Cash (Debt)	6.19	11.68	15.46	18.51	18.11
Net Cash Growth	-47.00%	-24.43%	-16.48%	2.20%	-27.94%
Net Cash Per Share	0.07	0.14	0.18	0.21	0.21
Book Value	40.48	39.86	40.79	42.51	40.65
Book Value Per Share	0.48	0.47	0.48	0.49	0.48
Tangible Book Value	24.4	24.44	25.52	27.29	27.83
Tangible Book Value Per Share	0.29	0.29	0.30	0.32	0.33